InsiderClue
Insiders · Profile

Caforio Giovanni

Board Chair and CEO at Bristol Myers Squibb. Filing since 24 Aug 2012. CIK 0001533201

Company
Date
Role
Action
Shares
Amount
Of holding
BMY Bristol Myers Squibb
6 Feb 2023
Board Chair and CEO
Sold, plan not stated
240,000
$17.92M
50.4%
BMY Bristol Myers Squibb
20 Sep 2022
Board Chair and CEO
Sold, plan not stated
25,000
$1.74M
5.0%
BMY Bristol Myers Squibb
15 Sep 2022
Board Chair and CEO
Sold, plan not stated
50,000
$3.59M
9.1%
BMY Bristol Myers Squibb
13 Jun 2022
Board Chair and CEO
Sold, plan not stated
30,000
$2.22M
5.2%
BMY Bristol Myers Squibb
21 Mar 2022
Board Chair and CEO
Sold, plan not stated
25,000
$1.79M
4.1%
BMY Bristol Myers Squibb
24 Feb 2022
Board Chair and CEO
Sold, plan not stated
30,000
$2.01M
6.2%
BMY Bristol Myers Squibb
20 Sep 2021
Board Chair and CEO
Sold, plan not stated
25,000
$1.52M
4.9%
BMY Bristol Myers Squibb
2 Aug 2021
Chairman and CEO
Sold, plan not stated
20,000
$1.37M
3.8%
BMY Bristol Myers Squibb
22 Mar 2021
Chairman and CEO
Sold, plan not stated
25,000
$1.56M
4.5%
BMY Bristol Myers Squibb
31 Aug 2020
Chairman and CEO
Sold, plan not stated
39,840
$2.50M
8.2%
BMY Bristol Myers Squibb
3 May 2016
Chief Executive Officer
Sold, plan not stated
34,594
$2.47M
22.8%
BMY Bristol Myers Squibb
17 Feb 2016
Chief Executive Officer
Sold, plan not stated
12,040
$765.53K
13.6%
BMY Bristol Myers Squibb
15 Sep 2014
Chief Operating Officer
Sold, plan not stated
26,691
$1.33M
39.6%
BMY Bristol Myers Squibb
24 Feb 2014
EVP & Chief Commercial Officer
Sold, plan not stated
41,563
$2.26M
45.5%
BMY Bristol Myers Squibb
31 May 2013
Pres., US Pharmaceuticals
Sold, plan not stated
10,538
$495.92K
18.2%
BMY Bristol Myers Squibb
23 May 2013
Pres., US Pharmaceuticals
Sold, plan not stated
26,647
$1.23M
31.5%
BMY Bristol Myers Squibb
27 Feb 2013
Pres., US Pharmaceuticals
Sold, plan not stated
12,150
$450.52K
19.0%
BMY Bristol Myers Squibb
28 Jan 2013
Pres., US Pharmaceuticals
Sold, plan not stated
20,350
$736.47K
24.1%
BMY Bristol Myers Squibb
24 Aug 2012
Pres., US Pharmaceuticals
Sold, plan not stated
25,900
$846.67K
31.1%
19 decisions on file.